Form 8-K - Current report:
SEC Accession No. 0001213900-24-091767
Filing Date
2024-10-29
Accepted
2024-10-29 16:42:32
Documents
15
Period of Report
2024-10-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea021903001-8k_aditxt.htm   iXBRL 8-K 27994
2 PRESS RELEASE DATED OCTOBER 29, 2024 ea021903001ex99-1_aditxt.htm EX-99.1 12934
3 GRAPHIC image_001.jpg GRAPHIC 2798
  Complete submission text file 0001213900-24-091767.txt   225169

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE adtx-20241023.xsd EX-101.SCH 3018
5 XBRL LABEL FILE adtx-20241023_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE adtx-20241023_pre.xml EX-101.PRE 22361
17 EXTRACTED XBRL INSTANCE DOCUMENT ea021903001-8k_aditxt_htm.xml XML 3786
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 241406342
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)